Effects of Osteopathic Manipulative Treatment Protocol on Sleep Quality in Parkinson's Disease Subjects

NCT ID: NCT06671600

Last Updated: 2025-03-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-08

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Parkinsonism, mainly caused by Parkinsons disease (PD), includes symptoms like tremors, stiffness, slow movements, and balance problems. These symptoms can make it hard for people to sleep well, which leads to a lower quality of life and can increase the risk of other health issues and cognitive decline.

Osteopathic manipulative treatment (OMT) is a hands-on approach that may help improve sleep without the side effects of traditional treatments. While OMT has shown promise in enhancing sleep, no studies have specifically looked at its effects on sleep in Parkinson's disease patients.

This study aims to see if OMT can help improve sleep quality, cognitive function, and daily activities for people with PD. The investigators will focus on treating specific areas of the body, using techniques that have helped improve sleep in the past.

Participants will be divided into two groups: one will receive OMT, while the other will get a light touch treatment as a control. Sleep surveys and data from Fitbit devices will be used to compare the effects of the two treatments. Additionally, cognitive function will be assessed using a specific task called the Stroop task.

This research could show that OMT can be a valuable addition to treatments for improving sleep quality in people with Parkinsons disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Parkinsonism is primarily linked to Parkinsons disease (PD) and presents a range of symptoms including tremors at rest, muscle stiffness, slowed movement (bradykinesia), and difficulties with balance. These symptoms can significantly disrupt sleep patterns, making it challenging for individuals to both fall asleep and stay asleep. As a result, many patients experience reduced sleep quality, which can adversely affect their overall well-being and make them more vulnerable to additional health problems, including cognitive decline.

Osteopathic manipulative treatment (OMT) is a holistic, hands-on therapy aimed at enhancing the body's natural ability to heal and function. It focuses on manipulating the body's muscles and joints to improve circulation and promote relaxation, which may lead to better sleep outcomes. Unlike some conventional treatments that often come with unwanted side effects, OMT offers a potentially safer, individualized approach to managing sleep disorders, especially in the context of Parkinsons disease.

Despite the promising indications that OMT could improve sleep quality, there has been a lack of focused research on its application specifically for patients with Parkinsons disease. This study aims to fill that gap by investigating how targeted OMT can influence sleep quality, cognitive function, and daily activities in individuals diagnosed with PD.

The treatment protocol will specifically target areas of the body such as the cranial, cervical, thoracic, and rib regions, using established OMT techniques that have previously shown efficacy in enhancing sleep quality. Participants will be assigned to one of two groups: the treatment group receiving OMT and a control group receiving a light touch treatment, which serves as a placebo.

To assess the effectiveness of the OMT, the investigators will employ a variety of measurement tools. Sleep quality will be evaluated through self-reported surveys as well as objective data collected using Fitbit devices, which can track sleep patterns and quality metrics. Additionally, cognitive function, particularly executive function, will be assessed through the Stroop task, a well-established cognitive test that measures a persons ability to manage conflicting information.

By systematically comparing the outcomes of the OMT group to those of the control group, this research aims to demonstrate the potential benefits of OMT as a complementary treatment for improving sleep quality in patients with Parkinsons disease. The findings could pave the way for integrating OMT into standard care practices, ultimately enhancing the quality of life for individuals living with this challenging condition.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinsons Disease Sleep

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants will be randomly divided into either the treatment group who will receive OMT and the sham group who will receive light touch.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment Group (OMT)

For the Osteopathic Manipulative Medicine(OMM) treatment group, an osteopathic manipulative treatment protocol will be applied to the cranial, cervical, thoracic, and ribcage regions. OMM procedures performed on the treatment group will consist of

1. suboccipital decompression/release
2. base spread
3. occipitoatlantal (OA) decompression
4. venous sinus drainage
5. compression of the fourth ventricle
6. cervical myofascial (unilateralperpendicular stretch)
7. thoracic inlet release (direct or indirect)
8. Bilateral rib raising
9. thoracoabdominal diaphragm doming (direct technique)
10. pedal pump (Dalrymple lymphatic pump). All aforementioned techniques are based on the protocol from Foundations of Osteopathic Medicine.

Group Type EXPERIMENTAL

Osteopathic Manipulative Treatment

Intervention Type PROCEDURE

Osteopathic manipulative treatment(OMT) protocol will be applied to the cranial, cervical, thoracic, and ribcage regions. OMT procedures performed on the treatment group will consist of

1. suboccipital decompression/release
2. base spread
3. occipitoatlantal (OA) decompression
4. venous sinus drainage
5. compression of the fourth ventricle
6. cervical myofascial (unilateral perpendicular stretch)
7. thoracic inlet release (direct or indirect)
8. Bilateral rib raising
9. thoracoabdominal diaphragm doming (direct technique)
10. pedal pump (Dalrymple lymphatic pump)

Sham- light touch

The sham group will serve as the control group and will receive a light touch-control procedure based on prior study utilizing light touch

Group Type SHAM_COMPARATOR

Sham (No Treatment)

Intervention Type PROCEDURE

The sham group will serve as the control group and will receive a light touch-control procedure based on prior study utilizing light touch.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Osteopathic Manipulative Treatment

Osteopathic manipulative treatment(OMT) protocol will be applied to the cranial, cervical, thoracic, and ribcage regions. OMT procedures performed on the treatment group will consist of

1. suboccipital decompression/release
2. base spread
3. occipitoatlantal (OA) decompression
4. venous sinus drainage
5. compression of the fourth ventricle
6. cervical myofascial (unilateral perpendicular stretch)
7. thoracic inlet release (direct or indirect)
8. Bilateral rib raising
9. thoracoabdominal diaphragm doming (direct technique)
10. pedal pump (Dalrymple lymphatic pump)

Intervention Type PROCEDURE

Sham (No Treatment)

The sham group will serve as the control group and will receive a light touch-control procedure based on prior study utilizing light touch.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must have a diagnosis of Parkinson's disease as per a neurologist
* Severity of 0-3 on the Hoehn and Yahr (H-Y) Scale
* Able to receive OMM
* Able to be in a supine and prone position.
* Able to wear a Fitbit watch and an oxygen saturation ring for the duration of the study (including when sleeping).
* Have sleep disturbance complaints.

Exclusion Criteria

* Patients on medications that affect sleep
* Have a pre-existing sleep disorder diagnosis
* Those who have a concurrent neurological diagnosis that would confound sleep patterns (ie. narcolepsy)
* Contraindications to the OMM techniques used in this protocol
* Severity of 4 and 5 on the Hoehn and Yahr Scale
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

New York Institute of Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sheldon Yao, Doctor of Osteopathic Medicine

Role: CONTACT

516-686-3799

References

Explore related publications, articles, or registry entries linked to this study.

Hablitz LM, Nedergaard M. The Glymphatic System: A Novel Component of Fundamental Neurobiology. J Neurosci. 2021 Sep 15;41(37):7698-7711. doi: 10.1523/JNEUROSCI.0619-21.2021.

Reference Type BACKGROUND
PMID: 34526407 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NYIT IRB-2025-158

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Manual Therapy in Parkinson's Disease
NCT06853262 RECRUITING NA
NMT for Parkinson's Disease
NCT03049033 RECRUITING NA
Sleep, Awake & Move - Part I
NCT02723396 COMPLETED